Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer

被引:77
作者
Zhou, Liangfu [1 ]
Zhao, Bin [1 ]
Zhang, Lixiu [1 ]
Wang, Shenghang [1 ]
Dong, Dandan [1 ]
Lv, Huanhuan [1 ,2 ,3 ]
Shang, Peng [2 ,3 ]
机构
[1] Northwestern Polytech Univ, Sch Life Sci, Xian 710072, Peoples R China
[2] Northwestern Polytech Univ, Res & Dev Inst Shenzhen, Shenzhen 518057, Peoples R China
[3] Northwestern Polytech Univ, Key Lab Space Biosci & Biotechnol, Inst Special Environm Biophys, Xian 710072, Peoples R China
基金
中国国家自然科学基金;
关键词
iron metabolism; cancer; iron chelators; targeted therapy; redox homeostasis; HEPATOCELLULAR-CARCINOMA CELLS; TRANSCRIPTION FACTOR NRF2; TRANSFERRIN RECEPTOR 2; HUMAN BREAST-CANCER; H-FERRITIN; IN-VIVO; REGULATORY PROTEIN-1; ANTITUMOR-ACTIVITY; PROSTATE-CANCER; TUMOR-GROWTH;
D O I
10.3390/ijms19051545
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Iron is an essential element for the growth and proliferation of cells. Cellular iron uptake, storage, utilization and export are tightly regulated to maintain iron homeostasis. However, cellular iron metabolism pathways are disturbed in most cancer cells. To maintain rapid growth and proliferation, cancer cells acquire large amounts of iron by altering expression of iron metabolism- related proteins. In this paper, normal cellular iron metabolism and the alterations of iron metabolic pathways in cancer cells were summarized. Therapeutic strategies based on targeting the altered iron metabolism were also discussed and disrupting redox homeostasis by intracellular high levels of iron provides new insight for cancer therapy. Altered iron metabolism constitutes a promising therapeutic target for cancer therapy.
引用
收藏
页数:21
相关论文
共 190 条
[11]   NCOA4 Deficiency Impairs Systemic Iron Homeostasis [J].
Bellelli, Roberto ;
Federico, Giorgia ;
Matte', Alessandro ;
Colecchia, David ;
Iolascon, Achille ;
Chiariello, Mario ;
Santoro, Massimo ;
De Franceschi, Lucia ;
Carlomagno, Francesca .
CELL REPORTS, 2016, 14 (03) :411-421
[12]   Artemisinin and its derivatives in cancer therapy: status of progress, mechanism of action, and future perspectives [J].
Bhaw-Luximon, Archana ;
Jhurry, Dhanjay .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (03) :451-466
[13]   Ferritin Nanocages: A Novel Platform for Biomedical Applications [J].
Bhushan, Bharat ;
Kumar, S. Uday ;
Matai, Ishita ;
Sachdev, Abhay ;
Dubey, Poornima ;
Gopinath, P. .
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY, 2014, 10 (10) :2950-2976
[14]   Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease [J].
Bogdan, Alexander R. ;
Miyazawa, Masaki ;
Hashimoto, Kazunori ;
Tsuji, Yoshiaki .
TRENDS IN BIOCHEMICAL SCIENCES, 2016, 41 (03) :274-286
[15]   Overexpression of cellular iron import proteins is associated with malignant progression of Esophageal adenocarcinoma [J].
Boult, Jessica ;
Roberts, Keith ;
Brookes, Matthew J. ;
Hughes, Sharon ;
Bury, Jonathan P. ;
Cross, Simon S. ;
Anderson, Gregory J. ;
Spychal, Robert ;
Lqbal, Tariq ;
Tselepis, Chris .
CLINICAL CANCER RESEARCH, 2008, 14 (02) :379-387
[16]   Iron-sulfur cluster biogenesis and trafficking in mitochondria [J].
Braymer, Joseph J. ;
Lill, Roland .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2017, 292 (31) :12754-12763
[17]   Non-transferrin bound iron: A key role in iron overload and iron toxicity [J].
Brissot, Pierre ;
Ropert, Martine ;
Le Lan, Caroline ;
Loreal, Olivier .
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2012, 1820 (03) :403-410
[18]   Modulation of iron transport proteins in human colorectal carcinogenesis [J].
Brookes, M. J. ;
Hughes, S. ;
Turner, F. E. ;
Reynolds, G. ;
Sharma, N. ;
Ismail, T. ;
Berx, G. ;
McKie, A. T. ;
Hotchin, N. ;
Anderson, G. J. ;
Iqbal, T. ;
Tselepis, C. .
GUT, 2006, 55 (10) :1449-1460
[19]   Catalytic metals, ascorbate and free radicals: Combinations to avoid [J].
Buettner, GR ;
Jurkiewicz, BA .
RADIATION RESEARCH, 1996, 145 (05) :532-541
[20]   Cancer cells with irons in the fire [J].
Bystrom, Laura M. ;
Rivella, Stefano .
FREE RADICAL BIOLOGY AND MEDICINE, 2015, 79 :337-342